• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者的代谢组学特征。

Metabolomic profile of systemic sclerosis patients.

机构信息

Dipartimento di Scienze Biomediche, Università di Cagliari, Cagliari, Italy.

Dipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, Ancona, Italy.

出版信息

Sci Rep. 2018 May 16;8(1):7626. doi: 10.1038/s41598-018-25992-7.

DOI:10.1038/s41598-018-25992-7
PMID:29769578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5955890/
Abstract

Systemic sclerosis (SSc) is an autoimmune disease of unknown aetiology characterized by vascular lesions, immunological alterations and diffuse fibrosis of the skin and internal organs. Since recent evidence suggests that there is a link between metabolomics and immune mediated disease, serum metabolic profile of SSc patients and healthy controls was investigated by H-NMR and GC-MS techniques. The results indicated a lower level of aspartate, alanine, choline, glutamate, and glutarate in SSc patients compared with healthy controls. Moreover, comparing patients affected by limited SSc (lcSSc) and diffuse SSc (dcSSc), 6 discriminant metabolites were identified. The multivariate analysis performed using all the metabolites significantly different revealed glycolysis, gluconeogenesis, energetic pathways, glutamate metabolism, degradation of ketone bodies and pyruvate metabolism as the most important networks. Aspartate, alanine and citrate yielded a high area under receiver-operating characteristic (ROC) curves (AUC of 0.81; CI 0.726-0.93) for discriminating SSc patients from controls, whereas ROC curve generated with acetate, fructose, glutamate, glutamine, glycerol and glutarate (AUC of 0.84; CI 0.7-0.98) discriminated between lcSSc and dcSSc. These results indicated that serum NMR-based metabolomics profiling method is sensitive and specific enough to distinguish SSc from healthy controls and provided a feasible diagnostic tool for the diagnosis and classification of the disease.

摘要

系统性硬化症(SSc)是一种病因不明的自身免疫性疾病,其特征为血管损伤、免疫改变以及皮肤和内脏的弥漫性纤维化。由于最近的证据表明代谢组学与免疫介导的疾病之间存在联系,因此通过 H-NMR 和 GC-MS 技术研究了 SSc 患者和健康对照者的血清代谢谱。结果表明,与健康对照者相比,SSc 患者的天冬氨酸、丙氨酸、胆碱、谷氨酸和戊二酸水平较低。此外,比较局限性 SSc(lcSSc)和弥漫性 SSc(dcSSc)患者,鉴定出 6 种有区别的代谢物。使用所有差异显著的代谢物进行的多元分析表明,糖酵解、糖异生、能量途径、谷氨酸代谢、酮体降解和丙酮酸代谢是最重要的网络。天冬氨酸、丙氨酸和柠檬酸对区分 SSc 患者和对照组具有较高的接收者操作特征(ROC)曲线下面积(AUC 为 0.81;CI 为 0.726-0.93),而使用醋酸盐、果糖、谷氨酸、谷氨酰胺、甘油和戊二酸生成的 ROC 曲线(AUC 为 0.84;CI 为 0.7-0.98)则可以区分 lcSSc 和 dcSSc。这些结果表明,基于血清 NMR 的代谢组学分析方法足够敏感和特异,可以区分 SSc 与健康对照者,并为该疾病的诊断和分类提供了一种可行的诊断工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/3d71b93536a7/41598_2018_25992_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/efbef2a6b386/41598_2018_25992_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/bd00adba6ce5/41598_2018_25992_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/80a940680e67/41598_2018_25992_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/93d4a90292e6/41598_2018_25992_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/5b24731b5b9a/41598_2018_25992_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/3d71b93536a7/41598_2018_25992_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/efbef2a6b386/41598_2018_25992_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/bd00adba6ce5/41598_2018_25992_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/80a940680e67/41598_2018_25992_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/93d4a90292e6/41598_2018_25992_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/5b24731b5b9a/41598_2018_25992_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae21/5955890/3d71b93536a7/41598_2018_25992_Fig6_HTML.jpg

相似文献

1
Metabolomic profile of systemic sclerosis patients.系统性硬化症患者的代谢组学特征。
Sci Rep. 2018 May 16;8(1):7626. doi: 10.1038/s41598-018-25992-7.
2
Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.血清中炎症蛋白水平升高提示系统性硬化症的早期阶段。
Arthritis Rheumatol. 2017 Dec;69(12):2359-2369. doi: 10.1002/art.40243. Epub 2017 Oct 30.
3
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.系统性硬化症中身体成分、骨矿物质密度、皮肤纤维化与血清25(OH)维生素D水平之间的关系
PLoS One. 2015 Sep 16;10(9):e0137912. doi: 10.1371/journal.pone.0137912. eCollection 2015.
4
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.西班牙系统性硬皮病网络注册研究:根据皮肤亚型和免疫状态的临床表现。
Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.
5
Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.血清半乳糖凝集素-3 水平:与系统性硬皮病患者纤维化、异常血管生成和免疫激活的可能相关性。
J Rheumatol. 2012 Mar;39(3):539-44. doi: 10.3899/jrheum.110755. Epub 2012 Jan 15.
6
Spleen elastography in patients with Systemic sclerosis.系统性硬皮病患者的脾脏弹性成像。
Rheumatol Int. 2021 Mar;41(3):633-641. doi: 10.1007/s00296-020-04772-5. Epub 2021 Jan 25.
7
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis.血清代谢组学分析揭示系统性硬化症的潜在生物标志物。
Metabolism. 2023 Jul;144:155587. doi: 10.1016/j.metabol.2023.155587. Epub 2023 May 6.
8
Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.系统性硬皮病患者血清表面活性蛋白 D 浓度:间质性肺病严重程度的潜在标志物。
Best Pract Res Clin Rheumatol. 2018 Aug;32(4):541-549. doi: 10.1016/j.berh.2019.01.005. Epub 2019 Feb 14.
9
T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.系统性硬化症中T细胞和自然杀伤细胞的表型异常:一项队列研究及综合文献综述
Clin Rev Allergy Immunol. 2015 Dec;49(3):347-69. doi: 10.1007/s12016-015-8505-8.
10
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.由于 Fli1 缺陷导致组织蛋白酶 V 表达减少,导致系统性硬化症皮肤纤维化和增生性血管病变的发展。
Rheumatology (Oxford). 2013 May;52(5):790-9. doi: 10.1093/rheumatology/kes379. Epub 2013 Jan 3.

引用本文的文献

1
NMR based clinical metabolomics revealed altered lipid and sugar metabolism in systemic sclerosis with implications for diagnosis and therapeutic strategies.基于核磁共振的临床代谢组学揭示了系统性硬化症中脂质和糖代谢的改变,这对诊断和治疗策略具有重要意义。
Sci Rep. 2025 Aug 21;15(1):30676. doi: 10.1038/s41598-025-16493-5.
2
Serum Metabolomic Profiling Reveals Differences Between Systemic Sclerosis Patients with Polyneuropathy.血清代谢组学分析揭示了合并多发性神经病的系统性硬化症患者之间的差异。
Int J Mol Sci. 2025 Jul 24;26(15):7133. doi: 10.3390/ijms26157133.
3
Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms.

本文引用的文献

1
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.系统性硬化症患者有和无胃肠道受累临床表现的肠道微生物群特征。
Sci Rep. 2017 Nov 1;7(1):14874. doi: 10.1038/s41598-017-14889-6.
2
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.代谢组学分析确定了多发性硬化症中改变的代谢途径。
Int J Biochem Cell Biol. 2017 Dec;93:148-155. doi: 10.1016/j.biocel.2017.07.004. Epub 2017 Jul 16.
3
The immunological function of GABAergic system.γ-氨基丁酸能系统的免疫功能。
肠道微生物组和代谢组学在系统性硬化症中的特征、关联和机制。
Front Immunol. 2024 Nov 4;15:1475528. doi: 10.3389/fimmu.2024.1475528. eCollection 2024.
4
Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis.解开免疫代谢之谜:解读系统性硬化症的发病机制。
Heliyon. 2024 Jul 31;10(15):e35445. doi: 10.1016/j.heliyon.2024.e35445. eCollection 2024 Aug 15.
5
Metabolomics in systemic sclerosis.系统性硬化症中的代谢组学。
Rheumatol Int. 2024 Oct;44(10):1813-1822. doi: 10.1007/s00296-024-05628-y. Epub 2024 Jul 9.
6
Metabolic fingerprinting of systemic sclerosis: a systematic review.系统性硬化症的代谢指纹图谱:一项系统综述。
Front Mol Biosci. 2023 Aug 8;10:1215039. doi: 10.3389/fmolb.2023.1215039. eCollection 2023.
7
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life.系统性硬化症患者参与正念减压方案:对其心理状态和生活质量的有益影响。
Int J Environ Res Public Health. 2023 Jan 31;20(3):2512. doi: 10.3390/ijerph20032512.
8
The Metabolomic Characterization of Different Types of Coronary Atherosclerotic Heart Disease in Male.男性不同类型冠状动脉粥样硬化性心脏病的代谢组学特征
Cardiol Res Pract. 2022 Jul 12;2022:6491129. doi: 10.1155/2022/6491129. eCollection 2022.
9
Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS.基于气相色谱-质谱联用技术的血浆代谢组学鉴定原发性免疫性血小板减少症(ITP)的代谢紊乱特征
Front Pharmacol. 2022 May 24;13:845275. doi: 10.3389/fphar.2022.845275. eCollection 2022.
10
Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis.血浆代谢组学分析揭示了系统性硬化症中四种可能受到干扰的机制。
Biomedicines. 2022 Mar 4;10(3):607. doi: 10.3390/biomedicines10030607.
Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1162-1172. doi: 10.2741/4539.
4
Urine metabolome profiling of immune-mediated inflammatory diseases.免疫介导的炎症性疾病的尿液代谢组学分析
BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8.
5
Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function.代谢组学揭示了巴氏综合征发病机制的新机制,并介绍了心磷脂在细胞功能中的新作用。
PLoS One. 2016 Mar 25;11(3):e0151802. doi: 10.1371/journal.pone.0151802. eCollection 2016.
6
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.(1)H-NMR 分析为多发性硬化症患者提供了代谢组学图谱。
Neurol Neuroimmunol Neuroinflamm. 2015 Dec 24;3(1):e185. doi: 10.1212/NXI.0000000000000185. eCollection 2016 Feb.
7
MetaboAnalyst 3.0--making metabolomics more meaningful.MetaboAnalyst 3.0——让代谢组学更具意义。
Nucleic Acids Res. 2015 Jul 1;43(W1):W251-7. doi: 10.1093/nar/gkv380. Epub 2015 Apr 20.
8
T-cell metabolism in autoimmune disease.自身免疫性疾病中的T细胞代谢
Arthritis Res Ther. 2015 Feb 11;17(1):29. doi: 10.1186/s13075-015-0542-4.
9
A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.活性氧物种介导的循环维持系统性硬化症患者皮肤成纤维细胞中 NADPH 氧化酶 2 和 4 的表达增加。
Arthritis Rheumatol. 2015 Jun;67(6):1611-22. doi: 10.1002/art.39084.
10
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.有胃肠道症状的系统性硬化症患者小肠细菌过度生长的患病率及预测因素
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-82-7. Epub 2014 Nov 3.